Source: BIOSPACE

Hyperion Therapeutics: Horizon Pharma Completes Acquisition Of Hyperion Therapeutics

DUBLIN, IRELAND--(Marketwired - May 07, 2015) - Horizon Pharma plc (NASDAQ: www.marketwire.com/mw/stock.jsp?TickerHZNP">HZNP), a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more